Dr Adam Woolley, clinical pharmacy specialist the the VA Boston Healthcare System and assistant clinical professor at the School of Pharmacy, Bouve College of Health Sciences, discusses how medication under dosing and under prescribing can result in poor patient outcomes and contribute to polypharmacy.
Dr. Adam Woolley, clinical pharmacy specialist the the VA Boston Healthcare System and assistant clinical professor at the School of Pharmacy, Bouve College of Health Sciences, discusses how medication under dosing and under prescribing can result in poor patient outcomes and contribute to polypharmacy.
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.